Compare eBay Inc (EBAY) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs IDEXX Laboratories, Inc. — how do they compare? eBay Inc trades at $112.56 (market cap $50.07B), while IDEXX Laboratories, Inc. trades at $576.8 (market cap $43.94B). The key difference: eBay Inc and IDEXX Laboratories, Inc. are close in size by market cap, and eBay Inc pays a 1.1% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| EBAY | IDXX | |
|---|---|---|
Market Cap | $50.07B | $43.94B |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $766.68 |
52-Week Low | $76.79 | $514.61 |
Enterprise Value | $53.41B | $44.84B |
Dividend Yield | 1.1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $112.54, down 2.22% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters with Q1 2026 EPS of $1.66 beating expectations of $1.58. Revenue growth accelerated to $11.1B in 2025, while maintaining robust profitability with 71.79% gross margins and 17.61% net income margin. Recent developments include the UK regulator clearing eBay's acquisition of Depop and ongoing market speculation about GameStop's takeover interest.
EBAY presents a mixed investment case with strong fundamentals offset by acquisition uncertainty. The stock trades above analyst consensus target of $108.78 despite recent weakness. Key opportunities include continued earnings momentum and advertising revenue growth, while risks center on competitive pressures and potential takeover volatility. Institutional sentiment remains cautiously optimistic with 46% buy ratings.
IDXX stock trades at $540.68, down 4.15% in the last session, with technical indicators showing a bearish bias. Fundamentally, the company demonstrates strong profitability with a 24.63% net margin and consistent earnings beats in recent quarters. Revenue growth continues, reaching $4.3B in 2025. Analyst sentiment remains predominantly positive with a 59% buy rating, though technical signals conflict with this fundamental strength.
The outlook balances robust fundamentals against technical weakness. Investment opportunity lies in sustained high profitability and market leadership in veterinary diagnostics, but risks include elevated valuation multiples (P/E 40.99) and bearish technical momentum that may pressure the stock near-term despite positive analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
